Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

 

→ About Us

 

→ Our papers

 

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
Welcome to the 17th issue of the AMYPAD newsletter
Welcome to the 17th issue of the AMYPAD newsletter 03 Jun 2021 We are writing to you with the latest news from the AMYPAD project......
AMYPAD Prognostic and Natural History Study reaches milestone of 1.000 research participants
AMYPAD Prognostic and Natural History Study reaches milestone of 1.000 research participants 31 May 2021 By the end of May 2021, 1.471 participants have been informed about the prognostic study, 1.001 consented......
Recruitment update
Recruitment update 31 May 2021 AMYPAD PHNS: currently 1.001 participants recruited of which 835 have been scanned......
Recruitment status (as 31 May, 2021)
Recruitment status (as 31 May, 2021)